The Co-agonist Site of NMDA-glutamate Receptors: A Novel Therapeutic Target for Age-related Cognitive Decline

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|32|5160-5168

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.32, 2014-10, pp. : 5160-5168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Plasma Levels of  -1-Anti-Chymotrypsin in Age-Related Cognitive Decline and Alzheimer's Disease: A Potential Therapeutic Target

By  

Current Pharmaceutical Design, Vol. 14, Iss. 26, 2008-09 ,pp. : 2659-2664

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate Binding-Site Ligands of NMDA Receptors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 36, 2011-12 ,pp. : 5483-5506

Bentham Science Publishers

Access to resources Recommend Favorite

Different age-related changes in NMDA and glycine receptors in the rat brain

By Davalos J.F.   Salim H.A.   P. Q.   Lopez-Anido R.   Barbero E.J.   Panintrarux C.   Adachi S.   Matsuno R.   Araki T.   Kato H.   Shuto K.   Fujiwara T.   Itoyama Y.  

Environmental Toxicology and Pharmacology, Vol. 1, Iss. 2, 1996-04 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Relationship between education and age‐related cognitive decline: a review of recent research

By  

Psychogeriatrics, Vol. 15, Iss. 2, 2015-06 ,pp. : 154-162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 187-206

Bentham Science Publishers

Access to resources Recommend Favorite